Results 91 to 100 of about 2,229 (127)

Diagnostic value of direct immunofluorescence in oral mucous membrane pemphigoid: a retrospective study. [PDF]

An Bras Dermatol
Jiang H, Wei P, Xu Z, Chen Y, Li B.
europepmc   +1 more source

Successful management of DPP-4 inhibitor-induced bullous pemphigoid with Stapokibart injection in an elderly diabetic patient: a case report. [PDF]

Front Med (Lausanne)
Yu M, Tian S, Meng F.
europepmc   +1 more source

Pemphigoid Antibodies in Patients with Oral Lichen Planus: A Systematic Review. [PDF]

Pathophysiology
De Falco D, Di Stasio D, Caggiula A, Lajolo C, Lucchese A, Petruzzi M.   +5 more
europepmc   +1 more source

The morbidity of systemic steroids: analyzing its use in bullous pemphigoid. [PDF]

An Bras Dermatol
Nieto-Benito LM, Suárez-Fernández R.
europepmc   +1 more source

Peptide Epitopes of NC16A BP180 in the Diagnostics of Bullous Pemphigoid. [PDF]

JID Innov
Lytton SD, Wagger C, Meyersburg D, Mussnig B, Lang R, Maglie R, Anzengruber F, Antiga E, Hall RP, Bauer JW.   +9 more
europepmc   +1 more source

Glucocorticoids Combined with Methotrexate in the Treatment of Psoriasis Merged with Bullous Pemphigoid: A Case Report and Literature Review. [PDF]

Clin Case Rep
Ma W, Li C, Miao H.
europepmc   +1 more source

Tyrosine kinase signaling pathways as therapeutic targets in autoimmune subepidermal blistering skin diseases (pemphigoid diseases). [PDF]

Front Immunol
Vikár S, Mócsai A.
europepmc   +1 more source

Autoimmune Bullous Diseases: Therapeutic Update. [PDF]

Drugs
Kasperkiewicz M, van Beek N, Schmidt E.
europepmc   +1 more source

Identification of distinct epitopes in dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid. [PDF]

Sci Adv
Mai S, Mai Y, Ujiie I, Izumi K, Natsuga K, Nishie W, Ujiie H.   +6 more
europepmc   +1 more source